Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:09 AM ET

Sponsor Check › Person

No photo found yet (own website and image search run after this page is viewed)

Mark Deem

Named as an officer, director or promoter on SEC Form D filings · MN, CA, WA · Jan 20, 2010 → Feb 10, 2025

10deals (issuers)

$306.5Mreported sold

231investors

46Form D filings

2010–2025years on file

Follow this person Look further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:21 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Mark Deem is listed as an executive officer and director on 46 SEC Form D filings by 10 issuers between Jan 2010 and Nov 2025. Largest by amount reported sold: Allay Therapeutics, Inc. (San Jose, CA — biotechnology — 2019–2025; $86.9M reported sold to 22 investors), CALA HEALTH, INC. (San Mateo, CA — other health care — 2016; $50.1M reported sold to 41 investors), NUVAIRA, INC. (Minneapolis, MN — other health care — 2012–2018; $42M reported sold to 49 investors), MIRAMAR LABS, INC. (Santa Clara, CA — other health care — 2010–2016; $35.8M reported sold to 10 investors), TWELVE, Inc. (Redwood City, CA — other health care — 2010–2015; $35.2M reported sold to 9 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $306.5M sold in total.

Listed alongside Hanson S. Gifford III (32 shared filings), Henry A. Plain, Jr. (27 shared filings), Nimesh Shah (17 shared filings), Maxim Gorbachev (10 shared filings), R. Michael Kleine (10 shared filings) and 54 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.

The issuers belong to 2 sponsor groups: Miramar Labs (2 issuers, $6.79M reported sold, 2010–2017) and Half (2 issuers, $82.8M reported sold, 2017–2025).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 22 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.

What this means 24 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 46 public filings for Mark Deem and found 11 differences: 4 Form Ds were filed more than 15 days after the first sale; Mark Deem's role changed at Allay Therapeutics, Inc.: executive officer, director → director; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Mark Deem has not run yet — it is joining a line of 8,079 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

22 cases: 13 closed (disposition not in docket feed), 9 dismissed

Deem v. Newrez, LLC closed

District Court, S.D. West Virginia · No. 2:24-cv-00401 · Filed Aug 5, 2024 · Closed Mar 13, 2025

Role of Deem: Plaintiff · Outcome: Terminated 2025-03-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in WV (not a filing state)

Joe Tex Xpress LLC v. Deem Structural Services LLC closed

District Court, E.D. Arkansas · No. 4:23-cv-00961 · Filed Oct 10, 2023 · Closed Jan 22, 2024 · Nature of suit: Other Fraud · Cause: 28:1332 Diversity-Fraud

Role of Deem Structural Services LLC: Defendant · Outcome: Terminated 2024-01-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in AR (not a filing state)

Deem v. Cintas Corporation No 2 closed

District Court, S.D. Ohio · No. 1:22-cv-00167 · Filed Mar 30, 2022 · Closed Jul 6, 2022

Role of Deem: Plaintiff · Outcome: Terminated 2022-07-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in OH (not a filing state)

DEEM v. INFINITI FINANCIAL SERVICES closed

District Court, D. New Jersey · No. 3:21-cv-20105 · Filed Nov 19, 2021 · Closed Jun 29, 2022 · Nature of suit: Consumer Credit · Cause: 28:1442 Notice of Removal

Role of DEEM: Plaintiff · Outcome: Terminated 2022-06-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in NJ (not a filing state)

Deem v. Juul Labs, Inc. closed

District Court, N.D. California · No. 3:20-cv-08964 · Filed Dec 15, 2020 · Closed May 21, 2021

Role of Deem: Plaintiff · Outcome: Terminated 2021-05-21 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in the person's filing state (CA)

Deem v. AFNI, Inc. dismissed

District Court, C.D. Illinois · No. 1:19-cv-01296 · Filed Sep 6, 2019 · Closed Jan 31, 2020 · Nature of suit: 480 Consumer credit

Role of Deem: Plaintiff · Outcome: Terminated 2020-01-31 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in IL (not a filing state)

GAR Disability Advocates, LLC v. Deem dismissed

District Court, E.D. Kentucky · No. 0:18-cv-00063 · Filed May 23, 2018 · Closed May 23, 2019 · Nature of suit: 290 Real Property: Other · Cause: 28:1332 Diversity-Conversion

Role of Deem: Defendant · Outcome: Terminated 2019-05-23 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in KY (not a filing state)

GAR DISABILITY ADVOCATES, LLC v. DEEM closed

District Court, D. New Jersey · No. 2:17-cv-04814 · Filed Jun 29, 2017 · Closed May 22, 2018 · Nature of suit: 290 Real Property: Other · Cause: 28:1332 Diversity-Conversion

Role of DEEM: Defendant · Outcome: Terminated 2018-05-22 — FJC Integrated Database disposition: Transfer to another district Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in NJ (not a filing state)

Deem v. Midland Funding LLC dismissed

District Court, W.D. Arkansas · No. 6:16-cv-06091 · Filed Sep 19, 2016 · Closed Dec 28, 2016 · Nature of suit: 480 Consumer Credit · Cause: 15:1692 Fair Debt Collection Act

Role of Deem: Plaintiff · Outcome: Terminated 2016-12-28 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in AR (not a filing state)

Deem v. GoPro, Inc. closed

District Court, N.D. California · No. 4:16-cv-00338 · Filed Jan 21, 2016 · Closed Apr 28, 2016 · Nature of suit: 850 Securities/Commodities · Cause: 12:22 Securities Fraud

Role of Deem: Plaintiff · Outcome: Terminated 2016-04-28 — FJC Integrated Database disposition: Statistical closing Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in the person's filing state (CA)

Deem, Inc. v. Travelport, LP dismissed

District Court, N.D. California · No. 4:15-cv-03683 · Filed Aug 12, 2015 · Closed Feb 4, 2016 · Nature of suit: 190 Contract: Other · Cause: 28:1332 Diversity-Breach of Contract

Role of Deem, Inc.: Plaintiff · Outcome: Terminated 2016-02-04 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); different first name (inc); court in the person's filing state (CA)

Deem v. Takeda Pharmaceuticals America Inc dismissed

District Court, W.D. Louisiana · No. 6:13-cv-00425 · Filed Feb 27, 2013 · Closed Aug 24, 2016 · Nature of suit: 367 Health care / pharm

Role of Deem: Plaintiff · Outcome: Terminated 2016-08-24 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in LA (not a filing state)

Deem v. Takeda Pharmaceuticals America, Inc. closed

District Court, S.D. Ohio · No. 2:12-cv-00786 · Filed Aug 29, 2012 · Closed Feb 27, 2013 · Nature of suit: 190 Other contract actions

Role of Deem: Plaintiff · Outcome: Terminated 2013-02-27 — FJC Integrated Database disposition: Multi-district litigation transfer Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in OH (not a filing state)

MidFirst Bank v. Deem dismissed

District Court, N.D. Ohio · No. 5:07-cv-03260 · Filed Oct 22, 2007 · Closed Dec 12, 2007 · Nature of suit: 220 Foreclosure

Role of Deem: Defendant · Outcome: Terminated 2007-12-12 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in OH (not a filing state)

DEEM v. AMERICAN STANDARD, INC. closed

District Court, E.D. Pennsylvania · No. 2:06-cv-60834 · Filed Aug 15, 2006 · Closed Jun 30, 2010

Role of DEEM: Plaintiff · Outcome: Terminated 2010-06-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in PA (not a filing state)

Merrill Lynch, Pierce, Fenner & Smith Incorporated v. Deem dismissed

District Court, S.D. West Virginia · No. 6:04-cv-00970 · Filed Sep 7, 2004 · Closed Sep 10, 2004 · Nature of suit: 850 Securities, Commodities, Exchange

Role of Deem: Defendant · Outcome: Terminated 2004-09-10 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in WV (not a filing state)

Deem v. Sears, Roebuck and Company closed

District Court, E.D. Michigan · No. 4:04-cv-40089 · Filed Mar 22, 2004 · Closed Apr 9, 2004 · Nature of suit: 380 Other personal property damage

Role of Deem: Plaintiff · Outcome: Terminated 2004-04-09 — FJC Integrated Database disposition: Remanded to state court Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in MI (not a filing state)

Deem Sum Intl Inc. v. BTW III Incorporated dismissed

District Court, N.D. California · No. 4:99-cv-03583 · Filed Jul 23, 1999 · Closed Apr 19, 2001 · Nature of suit: 290 Other real property actions

Role of Deem Sum Intl Inc.: Plaintiff · Outcome: Terminated 2001-04-19 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in the person's filing state (CA)

Deem v. Ford Motor Co closed

District Court, S.D. Ohio · No. 1:91-cv-00110 · Filed Feb 19, 1991 · Closed Dec 9, 1991

Role of Deem: Plaintiff · Outcome: Terminated 1991-12-09 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in OH (not a filing state)

Deem v. Ford Motor Co closed

District Court, S.D. Ohio · No. 1:91-mc-00022 · Filed Jan 28, 1991 · Closed Apr 2, 1992

Role of Deem: Plaintiff · Outcome: Terminated 1992-04-02 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in OH (not a filing state)

Deem v. Lockheed Corporation dismissed

District Court, S.D. New York · No. 1:87-cv-07017 · Filed Sep 30, 1987 · Closed Dec 2, 1992 · Nature of suit: 410 Antitrust

Role of Deem: Plaintiff · Outcome: Terminated 1992-12-02 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in NY (not a filing state)

UNITED STATES STEEL CORPORATION v. DEEM CORPORATION closed

District Court, S.D. Indiana · No. 1:84-cv-00895 · Filed May 23, 1984 · Closed Jan 30, 1985

Role of DEEM CORPORATION: Defendant · Outcome: Terminated 1985-01-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); surname only in the caption; court in IN (not a filing state)

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:21 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mark Deem..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

Mark E. Deem closed

United States Bankruptcy Court, E.D. Virginia · No. 04-11906 · Filed Apr 28, 2004 · Closed Feb 12, 2009

Role of Mark E. Deem: Debtor · Outcome: Case closed 2009-02-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); first name matches; court in VA (not a filing state)

Mark Wayne Deem and Amy Elizabeth Deem closed

United States Bankruptcy Court, S.D. California · No. 97-11707 · Filed Aug 8, 1997 · Closed Dec 22, 1997

Role of Mark Wayne Deem and Amy Elizabeth Deem: Debtor · Outcome: Case closed 1997-12-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗

same rare surname (3 people in Form D filings, 89 federal dockets); different first name (wayne); court in the person's filing state (CA)

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:21 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Mark Deem (compared 46 filings on Oct 24, 2026)

Note · Jan 29, 2016 – Nov 18, 2025

4 Form Ds were filed more than 15 days after the first sale

Form D filed 22 days after the first sale — Pleural Dynamics, Inc. · Form D filed 17 days after the first sale — Allay Therapeutics, Inc. · Form D filed 39 days after the first sale — NUVAIRA, INC. · Form D filed 18 days after the first sale — CALA HEALTH, INC.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Nov 18, 2025 ↗Pleural Dynamics, Inc. — PartnerFacts page ↗Form D · Feb 10, 2025 ↗Allay Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Nov 18, 2025 ↗ (Nov 18, 2025)
Pleural Dynamics, Inc. — PartnerFacts page ↗ (Nov 18, 2025)
Form D · Feb 10, 2025 ↗ (Feb 10, 2025)
Allay Therapeutics, Inc. — PartnerFacts page ↗ (Feb 10, 2025)
Form D · May 15, 2018 ↗ (May 15, 2018)
NUVAIRA, INC. — PartnerFacts page ↗ (Mar 4, 2026)
Form D · Feb 16, 2016 ↗ (Feb 16, 2016)
CALA HEALTH, INC. — PartnerFacts page ↗ (Dec 9, 2024)

Note · Feb 12, 2019 – May 1, 2020

Mark Deem's role changed at Allay Therapeutics, Inc.: executive officer, director → director

The Feb 12, 2019 filing lists Mark Deem as executive officer, director; the May 1, 2020 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 12, 2019 ↗Form D · May 1, 2020 ↗Mark Deem — PartnerFacts page ↗Allay Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Feb 12, 2019 ↗ (Feb 12, 2019)
Form D · May 1, 2020 ↗ (May 1, 2020)
Mark Deem — PartnerFacts page ↗
Allay Therapeutics, Inc. — PartnerFacts page ↗ (Feb 10, 2025)

Note · Jan 20, 2010 – Feb 4, 2025

10 offerings changed their target amount between filings

Offering amount changed between filings — Pleural Dynamics, Inc. · Offering amount changed between filings — Pleural Dynamics, Inc. · Offering amount lowered between filings — Pleural Dynamics, Inc. · Offering amount changed between filings — Allay Therapeutics, Inc. · Offering amount changed between filings — Allay Therapeutics, Inc. · and 5 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Dec 10, 2024 ↗Form D/A (later) · Feb 4, 2025 ↗Pleural Dynamics, Inc. — PartnerFacts page ↗Form D/A (earlier) · Mar 5, 2024 ↗

Sources

Form D/A (earlier) · Dec 10, 2024 ↗ (Dec 10, 2024)
Form D/A (later) · Feb 4, 2025 ↗ (Feb 4, 2025)
Pleural Dynamics, Inc. — PartnerFacts page ↗ (Nov 18, 2025)
Form D/A (earlier) · Mar 5, 2024 ↗ (Mar 5, 2024)
Form D/A (later) · Dec 10, 2024 ↗ (Dec 10, 2024)
Form D (earlier) · May 25, 2023 ↗ (May 25, 2023)
Form D/A (later) · Mar 5, 2024 ↗ (Mar 5, 2024)
Form D (earlier) · Sep 20, 2021 ↗ (Sep 20, 2021)

Note · Jan 11, 2010 – Feb 10, 2025

16 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Allay Therapeutics, Inc. (latest filing Feb 10, 2025) · No amendment in the last 12 months on an offering that may still be open — Pleural Dynamics, Inc. (latest filing Feb 4, 2025) · No amendment in the last 12 months on an offering that may still be open — Allay Therapeutics, Inc. (latest filing Jul 8, 2021) · No amendment in the last 12 months on an offering that may still be open — Allay Therapeutics, Inc. (latest filing Feb 12, 2019) · No amendment in the last 12 months on an offering that may still be open — NUVAIRA, INC. (latest filing May 15, 2018) · and 11 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Feb 10, 2025 ↗Allay Therapeutics, Inc. — PartnerFacts page ↗Form D/A · Feb 4, 2025 ↗Pleural Dynamics, Inc. — PartnerFacts page ↗

Sources

Form D · Feb 10, 2025 ↗ (Feb 10, 2025)
Allay Therapeutics, Inc. — PartnerFacts page ↗ (Feb 10, 2025)
Form D/A · Feb 4, 2025 ↗ (Feb 4, 2025)
Pleural Dynamics, Inc. — PartnerFacts page ↗ (Nov 18, 2025)
Form D/A · Jul 8, 2021 ↗ (Jul 8, 2021)
Form D · Feb 12, 2019 ↗ (Feb 12, 2019)
Form D · May 15, 2018 ↗ (May 15, 2018)
NUVAIRA, INC. — PartnerFacts page ↗ (Mar 4, 2026)

Note · Feb 12, 2019 – Dec 21, 2023

Industry group changed between filings — Allay Therapeutics, Inc.

"Other Technology" (Feb 12, 2019 to Sep 20, 2021); then "Biotechnology" (Dec 21, 2023 to Feb 10, 2025).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Feb 12, 2019 ↗Form D/A · Dec 21, 2023 ↗Allay Therapeutics, Inc. — PartnerFacts page ↗

Sources

Form D · Feb 12, 2019 ↗ (Feb 12, 2019)
Form D/A · Dec 21, 2023 ↗ (Dec 21, 2023)
Allay Therapeutics, Inc. — PartnerFacts page ↗ (Feb 10, 2025)

Note · Jan 20, 2010 – Jun 11, 2014

Industry group changed between filings — TWELVE, Inc.

"Other Technology" (Jan 20, 2010 to Apr 1, 2014); then "Other Health Care" (Jun 11, 2014 to Apr 28, 2015).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jan 20, 2010 ↗Form D · Jun 11, 2014 ↗TWELVE, Inc. — PartnerFacts page ↗

Sources

Form D · Jan 20, 2010 ↗ (Jan 20, 2010)
Form D · Jun 11, 2014 ↗ (Jun 11, 2014)
TWELVE, Inc. — PartnerFacts page ↗ (Apr 28, 2015)

Note · Apr 6, 2012 – Apr 7, 2014

Industry group changed between filings — NUVAIRA, INC.

"Other" (Apr 6, 2012 to Feb 21, 2013); then "Other Health Care" (Apr 7, 2014 to May 15, 2018).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 6, 2012 ↗Form D · Apr 7, 2014 ↗NUVAIRA, INC. — PartnerFacts page ↗

Sources

Form D · Apr 6, 2012 ↗ (Apr 6, 2012)
Form D · Apr 7, 2014 ↗ (Apr 7, 2014)
NUVAIRA, INC. — PartnerFacts page ↗ (Mar 4, 2026)

Note · Apr 6, 2012 – Dec 21, 2023

4 address changes between filings

Address moved from Menlo Park, CA to San Jose, CA — Allay Therapeutics, Inc. · Address moved from Sunnyvale, CA to Santa Clara, CA — MIRAMAR LABS, INC. · Address moved from Menlo Park, CA to Redwood City, CA — TWELVE, Inc. · Address moved from Bellevue, WA to Plymouth, MN — NUVAIRA, INC.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Sep 20, 2021 ↗Form D/A · Dec 21, 2023 ↗Allay Therapeutics, Inc. — PartnerFacts page ↗Form D · Dec 20, 2013 ↗

Sources

Form D · Sep 20, 2021 ↗ (Sep 20, 2021)
Form D/A · Dec 21, 2023 ↗ (Dec 21, 2023)
Allay Therapeutics, Inc. — PartnerFacts page ↗ (Feb 10, 2025)
Form D · Dec 20, 2013 ↗ (Dec 20, 2013)
Form D/A · Oct 6, 2014 ↗ (Oct 6, 2014)
MIRAMAR LABS, INC. — PartnerFacts page ↗ (May 23, 2016)
Form D · Jun 11, 2012 ↗ (Jun 11, 2012)
Form D · Apr 1, 2014 ↗ (Apr 1, 2014)

Note · Jan 20, 2010 – Nov 18, 2025

Mark Deem is listed with 3 different address states: CA, WA, MN

CA on 37 filings (Jan 20, 2010 to Feb 10, 2025); WA on 1 filing (Apr 6, 2012); MN on 8 filings (Feb 21, 2013 to Nov 18, 2025).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jan 20, 2010 ↗Form D · Apr 6, 2012 ↗Form D · Feb 21, 2013 ↗

Sources

Note · Dec 20, 2013 – Oct 6, 2014

Minimum investment changed between filings — MIRAMAR LABS, INC.

The Dec 20, 2013 filing lists a minimum of $0; the Oct 6, 2014 Form D/A lists $1.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Dec 20, 2013 ↗Form D/A (later) · Oct 6, 2014 ↗MIRAMAR LABS, INC. — PartnerFacts page ↗

Sources

Form D (earlier) · Dec 20, 2013 ↗ (Dec 20, 2013)
Form D/A (later) · Oct 6, 2014 ↗ (Oct 6, 2014)
MIRAMAR LABS, INC. — PartnerFacts page ↗ (May 23, 2016)

Note · Sep 28, 2010 – May 11, 2011

Minimum investment changed between filings — CABOCHON AESTHETICS INC

The Sep 28, 2010 filing lists a minimum of $0; the May 11, 2011 Form D/A lists $1.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Sep 28, 2010 ↗Form D/A (later) · May 11, 2011 ↗CABOCHON AESTHETICS INC — PartnerFacts page ↗

Sources

Form D (earlier) · Sep 28, 2010 ↗ (Sep 28, 2010)
Form D/A (later) · May 11, 2011 ↗ (May 11, 2011)
CABOCHON AESTHETICS INC — PartnerFacts page ↗ (Oct 21, 2013)

What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 34 offerings reports sales commissions totalling $129,480; 0 report finder's fees; 1 reports proceeds to related persons totalling $580,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)	Sales commissions	Finder's fees	To insiders	Paid to sell it	Source
Nov 18, 2025 D Pleural Dynamics, Inc. File 021-564290	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 10, 2025 D Allay Therapeutics, Inc. File 021-537818	$0 (est.)	$0 (est.)	$0 (est.)	None listed on this filing	EDGAR ↗
Feb 4, 2025 D/A Pleural Dynamics, Inc. File 021-482663	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 21, 2023 D/A Allay Therapeutics, Inc. File 021-413904	$0 (est.)	$0 (est.)	$0 (est.)	None listed on this filing	EDGAR ↗
Feb 22, 2023 D Half Moon Medical, Inc. File 021-473977	$0	$0	$0	None listed on this filing	EDGAR ↗
Jul 8, 2021 D/A Allay Therapeutics, Inc. File 021-366171	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 19, 2019 D Half Moon Medical, Inc. File 021-333098	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 12, 2019 D Allay Therapeutics, Inc. File 021-332700	$0	$0	$0	None listed on this filing	EDGAR ↗
May 15, 2018 D NUVAIRA, INC. File 021-312401	$0	$0	$0 Excludes standard compensation for officers and directors.	None listed on this filing	EDGAR ↗
May 24, 2017 D Half Moon Medical, Inc. File 021-287371	$0	$0	$0	None listed on this filing	EDGAR ↗
May 24, 2017 D Half Moon Medical, Inc. File 021-287372	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 9, 2017 D MIRAMAR LABS, INC. File 021-280384	$0	$0	$0	None listed on this filing	EDGAR ↗
Aug 5, 2016 D/A MIRAMAR LABS, INC. File 021-265490	$129,480	$0	$0 (est.)	The Benchmark Company, LLC BrokerCheck CRD 22982 ↗ Katalyst Securities LLC BrokerCheck CRD 112494 ↗	EDGAR ↗
Jun 21, 2016 D MIRAMAR LABS, INC. File 021-265489	$0	$0	$0 (est.)	None listed on this filing	EDGAR ↗
May 23, 2016 D/A MIRAMAR LABS, INC. File 021-258315	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 16, 2016 D CALA HEALTH, INC. File 021-257489	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 23, 2015 D MIRAMAR LABS, INC. File 021-253743	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 28, 2015 D TWELVE, Inc. File 021-238748	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 6, 2014 D/A MIRAMAR LABS, INC. File 021-208433	$0	$0	$0	None listed on this filing	EDGAR ↗
Jul 9, 2014 D/A TWELVE, Inc. File 021-218937	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 7, 2014 D NUVAIRA, INC. File 021-215002	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 1, 2014 D TWELVE, Inc. File 021-214622	$0	$0	$0	None listed on this filing	EDGAR ↗
Dec 11, 2013 D MIRAMAR LABS, INC. File 021-207782	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 21, 2013 D CABOCHON AESTHETICS INC File 021-204902	$0	$0	$0	None listed on this filing	EDGAR ↗
Feb 21, 2013 D NUVAIRA, INC. File 021-192202	$0	$0	$580,000 (est.) PROCEEDS MAY BE USED FOR SALARY AND BENEFITS OF DENNIS WAHR, AS CHIEF EXECUTIVE OFFICER, AND TO REIMBURSE EXPENSES FOR THE BOARD OF DIRECTORS	None listed on this filing	EDGAR ↗
Nov 13, 2012 D Cotera, Inc. File 021-186837	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 11, 2012 D TWELVE, Inc. File 021-179564	$0	$0	$0	None listed on this filing	EDGAR ↗
Apr 6, 2012 D NUVAIRA, INC. File 021-176273	$0	$0	$0	None listed on this filing	EDGAR ↗
Jan 19, 2012 D TWELVE, Inc. File 021-172154	$0	$0	$0	None listed on this filing	EDGAR ↗
Jun 1, 2011 D MIRAMAR LABS, INC. File 021-160606	$0	$0	$0	None listed on this filing	EDGAR ↗
May 11, 2011 D/A CABOCHON AESTHETICS INC File 021-148217	$0	$0	$0	None listed on this filing	EDGAR ↗
Mar 23, 2011 D/A TWELVE, Inc. File 021-138006	$0	$0	$0	None listed on this filing	EDGAR ↗
Nov 30, 2010 D MIRAMAR LABS, INC. File 021-151163	$0	$0	$0	None listed on this filing	EDGAR ↗
Oct 5, 2010 D MIRAMAR LABS, INC. File 021-148554	$0	$0	$0	None listed on this filing	EDGAR ↗

How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named Mark Deem on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Pleural Dynamics, Inc.

Wayzata, MN · May 25, 2023 → Nov 18, 2025 · 5 filings

Nov 18, 2025 · D · $618,000 sold of $4,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
Feb 4, 2025 · D/A · $7,710,767 sold of $8,521,054 · 29 investors · min. No minimum reported · role: Director EDGAR ↗
Dec 10, 2024 · D/A · $5,463,239 sold of $8,361,023 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
Mar 5, 2024 · D/A · $4,485,864 sold of $5,103,360 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
May 25, 2023 · D · $3,683,286 sold of $5,638,562 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.71M from 29 investors (100% of the $4M target) as of the latest filing. Mark is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Allay Therapeutics, Inc.

San Jose, CA · Feb 12, 2019 → Feb 10, 2025 · 6 filings

Feb 10, 2025 · D · $44,999,997 sold of $59,999,995 · 18 investors · min. $1 · role: Director EDGAR ↗
Dec 21, 2023 · D/A · $86,890,346 sold of $86,890,346 · 22 investors · min. $1 · role: Director EDGAR ↗
Sep 20, 2021 · D · $82,376,278 sold of $82,376,285 · 20 investors · min. $1 · role: Director EDGAR ↗
Jul 8, 2021 · D/A · $15,000,000 sold of $18,000,000 · 7 investors · min. $1 · role: Director EDGAR ↗
May 1, 2020 · D · $12,000,000 sold of $15,000,000 · 7 investors · min. $1 · role: Director EDGAR ↗
Feb 12, 2019 · D · $15,752,807 sold of $28,752,807 · 14 investors · min. $1 · role: Executive Officer, Director EDGAR ↗

Raised $86.9M from 22 investors (100% of the $60M target) as of the latest filing. Mark is listed as director, executive officer on 6 filings for this deal.

Latest filing on EDGAR ↗

Sources

Other Health Care · group: Half

Half Moon Medical, Inc.

Menlo Park, CA · May 24, 2017 → Feb 22, 2023 · 4 filings

Feb 22, 2023 · D · $1,000,000 sold of $1,000,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
Feb 19, 2019 · D · $1,000,000 sold of $1,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
May 24, 2017 · D · $5,165,000 sold of $5,165,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
May 24, 2017 · D · $1,000,000 sold of $1,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.17M from 12 investors (100% of the $1M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

NUVAIRA, INC.

Minneapolis, MN · Apr 6, 2012 → May 15, 2018 · 4 filings

May 15, 2018 · D · $4,000,011 sold of $8,000,023 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
Apr 7, 2014 · D · $42,000,011 sold of $42,000,011 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
Feb 21, 2013 · D · $10,000,000 sold of $10,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
Apr 6, 2012 · D · $10,600,007 sold of $10,600,007 · 16 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $42M from 49 investors (100% of the $8M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Miramar Labs

MIRAMAR LABS, INC.

Santa Clara, CA · Jun 21, 2016 → Feb 9, 2017 · 5 filings

Feb 9, 2017 · D · $2,464,735 sold of $3,000,000 · 3 investors · min. $1 · role: Director EDGAR ↗
Aug 5, 2016 · D/A · $9,571,815 sold of $15,520,477 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
Jul 13, 2016 · D/A · $9,377,415 sold of $15,520,477 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
Jun 21, 2016 · D · $9,098,300 sold of $15,520,477 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
Jun 21, 2016 · D · $33,575,527 sold of $33,575,527 · 36 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $33.6M from 36 investors (100% of the $3M target) as of the latest filing. Mark is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Miramar Labs

MIRAMAR LABS, INC.

Santa Clara, CA · Oct 5, 2010 → May 23, 2016 · 9 filings

May 23, 2016 · D/A · $4,326,723 sold of $4,850,000 · 8 investors · min. $1 · role: Director EDGAR ↗
Mar 1, 2016 · D · $2,018,617 sold of $2,700,000 · 5 investors · min. $1 · role: Director EDGAR ↗
Dec 23, 2015 · D · $1,261,635 sold of $1,500,000 · 5 investors · min. $1 · role: Director EDGAR ↗
Oct 6, 2014 · D/A · $26,008,213 sold of $26,008,213 · 7 investors · min. $1 · role: Director EDGAR ↗
Dec 20, 2013 · D · $10,008,213 sold of $25,008,213 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
Dec 11, 2013 · D · $5,000,000 sold of $5,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
Jun 1, 2011 · D · $35,846,047 sold of $36,000,000 · 10 investors · min. $1 · role: Director EDGAR ↗
Nov 30, 2010 · D · $1,750,000 sold of $4,500,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
Oct 5, 2010 · D · $1,000,000 sold of $1,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $35.8M from 10 investors (100% of the $4.85M target) as of the latest filing. Mark is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

CALA HEALTH, INC.

San Mateo, CA · Feb 16, 2016

Feb 16, 2016 · D · $17,999,994 sold of $17,999,994 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50.1M from 41 investors (100% of the $18M target) as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

TWELVE, Inc.

Redwood City, CA · Jan 20, 2010 → Apr 28, 2015 · 8 filings

Apr 28, 2015 · D · $35,249,982 sold of $35,349,980 · 9 investors · min. $1 · role: Director EDGAR ↗
Jul 9, 2014 · D/A · $14,075,943 sold of $14,075,943 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
Jun 11, 2014 · D · $9,075,943 sold of $12,075,942 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
Apr 1, 2014 · D · $7,000,000 sold of $7,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
Jun 11, 2012 · D · $14,849,997 sold of $15,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
Jan 19, 2012 · D · $1,500,000 sold of $1,500,000 · 5 investors · min. $1 · role: Director EDGAR ↗
Mar 23, 2011 · D/A · $4,000,000 sold of $4,050,000 · 6 investors · min. $1 · role: Director EDGAR ↗
Jan 20, 2010 · D · $3,000,000 sold of $3,000,000 · 4 investors · min. $1 · role: Director EDGAR ↗

Raised $35.2M from 9 investors (100% of the $35.3M target) as of the latest filing. Mark is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

CABOCHON AESTHETICS INC

Menlo Park, CA · Sep 28, 2010 → Oct 21, 2013 · 3 filings

Oct 21, 2013 · D · $400,000 sold of $600,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
May 11, 2011 · D/A · $2,187,458 sold of $2,536,500 · 13 investors · min. $1 · role: Director EDGAR ↗
Sep 28, 2010 · D · $1,398,613 sold of $2,006,819 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2.19M from 13 investors (100% of the $600K target) as of the latest filing. Mark is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

Cotera, Inc.

Menlo Park, CA · Nov 13, 2012

Nov 13, 2012 · D · $5,040,845 sold of $5,040,845 · 8 investors · min. $1 · role: Director EDGAR ↗

Raised $7.84M from 10 investors (100% of the $5.04M target) as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Mark 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

No photo found yet (own website and image search run after this page is viewed)

Person

Hanson S. Gifford III

Executive Officer, Director · 32 shared filings (7 issuers) · also on 5 other issuers

Hanson S. Gifford III is on 12 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Henry A. Plain, Jr.

Director · 27 shared filings (5 issuers) · also on 9 other issuers

Henry A. Plain, Jr. is on 14 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Nimesh Shah

Director · 17 shared filings (3 issuers) · also on 7 other issuers

Nimesh Shah is on 10 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

R. Michael Kleine

Executive Officer, Director · 10 shared filings (2 issuers)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Maxim Gorbachev

Director · 10 shared filings (2 issuers)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Charles Warden

Director · 8 shared filings (2 issuers) · also on 11 other issuers

Charles Warden is on 13 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Stacey Seltzer

Director · 8 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Brigid Makes

Executive Officer · 8 shared filings (2 issuers)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Steven Kim

Executive Officer · 8 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Michael Carusi

Director · 8 shared filings (3 issuers) · also on 14 other issuers

Michael Carusi is on 17 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Leighton Read

Director · 6 shared filings (1 issuer) · also on 4 other issuers

Leighton Read is on 5 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Brian H. Dovey

Director · 6 shared filings (2 issuers) · also on 13 other issuers

Brian H. Dovey is on 15 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Martin L. Mayse

Executive Officer, Director, Promoter · 5 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Josh Makower

Director · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Tak Cheung

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Robert Crutchfield

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Ben Brian

Executive Officer, Director · 4 shared filings (2 issuers)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Darrell Zoromski

Executive Officer, Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Adam Gridley

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Kirk Nielsen

Director · 4 shared filings (1 issuer) · also on 24 other issuers

Kirk Nielsen is on 25 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Russell Hirsch

Director · 3 shared filings (1 issuer) · also on 11 other issuers

Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Thomas J. Fogarty

Director · 3 shared filings (1 issuer) · also on 7 other issuers

Thomas J. Fogarty is on 8 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Andrew Cleeland

Executive Officer, Director · 3 shared filings (1 issuer) · also on 5 other issuers

Andrew Cleeland is on 6 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Dennis W. Wahr

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Stacy Seltzer

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Karun D. Naga

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Paul McCreadie

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

David Stassen

Director · 3 shared filings (2 issuers) · also on 7 other issuers

David Stassen is on 9 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Gintaras Vaisnys

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Richard Stark

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Dave Stassen

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Marc Galletti

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Marc Galletti is on 5 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Nicole Vitullo

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Ferolyn Powell

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Hank Plain

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Mike Carusi

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Matthew McLean

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Allan Will

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Allan Will is on 5 issuers in total — a repeat sponsor. Their page lists every one.

No photo found yet (own website and image search run after this page is viewed)

Person

Steven Dimmer

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Deem. Their page shows their other deals.

No photo found yet (own website and image search run after this page is viewed)

Person

Joshua J. Baltzell

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Joshua J. Baltzell is on 6 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Sponsor group

Miramar Labs

2 issuers · 14 filings · $6.79M reported sold · 2010–2017

ML MIRAMAR LABS, INC. Other Health Care · $33.6M sold · 2016 · listed
ML MIRAMAR LABS, INC. Other Health Care · $35.8M sold · 2010 · listed

One team, 2 deal companies. Mark Deem is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mark Deem.

Sponsor group

Half

2 issuers · 5 filings · $82.8M reported sold · 2017–2025

AH Apreo Health, Inc. Other Health Care · $81.8M sold · 2025
HM Half Moon Medical, Inc. Other Health Care · $5.17M sold · 2017 · listed

One team, 2 deal companies. Mark Deem is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mark Deem.

Same business address

6 other issuers file from the same address

Apreo Health, Inc. Menlo Park, CA · 2025
Sight Sciences, Inc. Menlo Park, CA · 2011
Aryaka Networks, Inc. San Mateo, CA · 2009
Transcend Medical Inc Menlo Park, CA · 2009
NEVRO CORP Menlo Park, CA · 2010
NEODYNE BIOSCIENCES INC Menlo Park, CA · 2010

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Mark Deem by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Mark Deem is listed on: none on file. No website or social profile named in MIRAMAR LABS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #276,749 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Santa Clara, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Mark Deem appears on a new Form D, or when a court case or SEC action is matched to them. See plans →

Mark Deem

The short version

What the community is saying

Key records

1. Lawsuits

2. Regulatory actions

3. Bankruptcies

4. Differences between public sources

4 Form Ds were filed more than 15 days after the first sale

Mark Deem's role changed at Allay Therapeutics, Inc.: executive officer, director → director

10 offerings changed their target amount between filings

16 offerings have no amendment in the last 12 months and may still be open

Industry group changed between filings — Allay Therapeutics, Inc.

Industry group changed between filings — TWELVE, Inc.

Industry group changed between filings — NUVAIRA, INC.

4 address changes between filings

Mark Deem is listed with 3 different address states: CA, WA, MN

Minimum investment changed between filings — MIRAMAR LABS, INC.

Minimum investment changed between filings — CABOCHON AESTHETICS INC

5. Money to insiders

Deals 10

People around Mark 40

The team behind the deals

6 other issuers file from the same address

Registrations and other filings

Adviser registration (Form ADV)

Other offering types (Regulation A and Regulation Crowdfunding)

Public profiles and social

Look further

Social and web

Courts

Securities regulators

Business registries

Change history

Request a correction

Add a response

Monitor this person